Citation:Henry L, Fabre C, Guiraud I, Bastide S, Fabbro-Peray P, Martinez J, et al 2013

From Cancer Guidelines Wiki

Citation


Henry L, Fabre C, Guiraud I, Bastide S, Fabbro-Peray P, Martinez J, et al. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein. Int J Cancer 2013 Jul;133(1):142-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23238767.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?
What investigations should be performed when in-transit and/or regional node disease (stage III melanoma) is diagnosed?
What investigations should be performed when stage IV melanoma is diagnosed?
Lyndal Alchincompleted
What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?
What investigations should be performed when in-transit and/or regional node disease (stage III melanoma) is diagnosed?
What investigations should be performed when stage IV melanoma is diagnosed?
Tamsin Parrishcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?, Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?, Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?</span>, <span class="smw-value">Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?</span>, <span class="smw-value">Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?, Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?, Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?</span>, <span class="smw-value">Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?</span>, <span class="smw-value">Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?